MarkusDSiegelinMD

Anatomic Pathology, Clinical Pathology

Physician

Dr. Siegelin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 2010 - 2013
Goethe University Frankfurt Medical FacultyClass of 2005

PubMed

12 citations
Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors.
Elena Bianchetti, S.J. Bates, Steven L. Carroll, Markus D. Siegelin, Kevin A. Roth
Scientific Reports. 2018-11-26
11 citations
Simultaneous Interference with HER1/EGFR and RAC1 Signaling Drives Cytostasis and Suppression of Survivin in Human Glioma Cells in Vitro
Georg Karpel-Massler, Mike-Andrew Westhoff, Richard E. Kast, Annika Dwucet, S. Karpel-Massler
Neurochemical Research. 2017-03-07
90 citations
Adaptive Mitochondrial Reprogramming and Resistance to PI3K Therapy
Jagadish C. Ghosh, Markus D. Siegelin, Valentina Vaira, Alice Faversani, Michele Tavecchio
Journal of the National Cancer Institute. 2015-03-01

Velocity Raises More Than $1.1 Million to End CancerNovember 28th, 2022
Three Columbia Physicians Named to American Society for Clinical InvestigationFebruary 14th, 2022
Clinical Cancer Research Article Describes Opportunity to Use Imipridones for Brain TumorsAugust 22nd, 2018